FDA’s authorizes coronavirus plasma treatment, Trump calls the step as a “a breakthrough

US President Donald Trump on Sunday announced emergency authorization to treat COVID-19 patients with convalescent plasma — a move he called “a breakthrough,”  after FDA authorization.

The U.S. Food & Drug Administration (FDA) announcement of its “emergency use authorization” of the treatment came on the eve of the Republican National Convention, where Trump will be nominated to lead his party for four more years.

At least 5,686,377 cases of COVID-19 have been reported in the United States, according to a Reuters tally, and more than 176,000 Americans have died.

Plasma is the element of blood that carries water, enzymes and blood cells throughout the body. It also carries the antibodies humans form to fight off disease and boost immunity.